ADHD Medication and Cardiovascular Risk

Plain-language summary

Research suggests that while ADHD medications can be very helpful, it's important to be aware of potential cardiovascular effects. While some studies show very small risks, others highlight the need for careful monitoring, especially in certain populations. The overall evidence indicates that these risks are generally low for most people but careful consideration of individual patient health is always recommended.

Key findings

• A comprehensive review indicated a slightly increased risk of cardiovascular diseases associated with ADHD medications, but this risk is generally small.
• Specific studies are needed to further understand the long-term cardiovascular safety of ADHD medications in people with pre-existing conditions like schizophrenia spectrum disorders.
• Some research points to the need for continued monitoring of cardiovascular side effects linked to ADHD medication use, particularly through global pharmacovigilance efforts.

Studies cited (5)

1. Risk of Cardiovascular Diseases Associated With Medications Used in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-analysis — Zhang L, Yao H, Li L (2022, JAMA network open, meta-analysis)

   DOI: 10.1001/jamanetworkopen.2022.43597 PMCID: PMC9685490

2. Long term safety of ADHD medication in patients with schizophrenia spectrum disorders — Luykx JJ, Corbeil O, Kärkkäinen O (2025, Molecular psychiatry, other)

   DOI: 10.1038/s41380-025-03080-3 PMCID: PMC12436181

3. Global burden of ADHD medication-associated cardiovascular disease, 1967-2023: A comparative analysis using the WHO pharmacovigilance database — Cho H, Lee K, Jeong YD (2024, Asian journal of psychiatry, other)

   DOI: 10.1016/j.ajp.2024.104209

4. Methylphenidate and Short-Term Cardiovascular Risk — Garcia-Argibay M, Bürkner PC, Lichtenstein P (2024, JAMA network open, other)

   DOI: 10.1001/jamanetworkopen.2024.1349 PMCID: PMC10918505

5. Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study — Man KKC, Häge A, Banaschewski T (2023, The lancet. Psychiatry, other)

   DOI: 10.1016/S2215-0366(23)00042-1